Convergence at the Nanoscale: Transformative Advances in Drug Delivery, Vaccinology, and Biomedical Diagnostics

Nanotechnology has become a disruptive technology in the field of medicine delivering solutions in diagnostics, therapeutics and vaccine development in a precise manner. The article gives a broad understanding of the development, processes and medical utilization of nanomaterial’s namely liposomes, dendrimers, polymeric carriers, and quantum dots as drug delivery and biosensing systems. Nano diagnostics in the form of lab-on-a-chip (LOC) and point-of-care (POC) testing holds tremendous potential in terms of determining pathogens quickly and multiplexed along with monitoring chronic conditions. An example of how nanomedicine is working in the real world occurred with the COVID-19 pandemic, which catalyzed the development of gold and magnetic nanoparticle-based diagnostics platforms into the field and mRNA-based vaccines. Notwithstanding these developments, there is still a set of troubles associated with scalability of manufacturing, standardization of regulations and ethical governance. The major ethical concerns are human enhancement, surveillance, and inequality in access to high-tech means on the global level. The article also discusses new technologies called DNA origami, nanobots and biohybrids-the ones which are expected to disrupt the precision medicine with the use of programmable and flexible systems. Being combined with genomics and systems biology, intelligent therapeutics that have dynamic molecular response are under way. Nevertheless, biocompatibility, autonomous regulation, and ostensibly fair use top modules are still subject to questioning. These grand challenges need multidisciplinary teamwork, a solid ethical ground, and convergence in regulatory approaches. The vision that was envisioned in this future is the ability of self-powered, AI-enabled Nano devices, providing real-time feedback, and able to transition the healthcare industry to a decentralized and personalized paradigm. The convergence of scientific novelty and social clarification empha

Authors

Publication Details

Journal
Scholars Academic Journal of Pharmacy
Published
2025-08-18
DOI
https://doi.org/10.36347/sajp.2025.v14i06.004
Citations
11
Primary Topic
Biosensors and Analytical Detection
Type
article
Field-Weighted Citation Impact
7.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Convergence at the Nanoscale: Transformative Advances in Drug Delivery, Vaccinology, and Biomedical Diagnostics

Muhammad Ali, Muhammad Khan, Amna Asif, Sayeed Ghani et al.
11 citations
Scholars Academic Journal of Pharmacy
Biosensors and Analytical Detection
7.42
article

Convergence at the Nanoscale: Transformative Advances in Drug Delivery, Vaccinology, and Biomedical Diagnostics

Muhammad Ali, Muhammad Khan, Amna Asif, Sayeed Ghani, Ayesha Suleman, Shazia Rafique, Khadija Amjad, Ayesha Aslam, Amna Shakeel, Position Irfan Ishaque
article en
11 citations

Abstract

Nanotechnology has become a disruptive technology in the field of medicine delivering solutions in diagnostics, therapeutics and vaccine development in a precise manner. The article gives a broad understanding of the development, processes and medical utilization of nanomaterial’s namely liposomes, dendrimers, polymeric carriers, and quantum dots as drug delivery and biosensing systems. Nano diagnostics in the form of lab-on-a-chip (LOC) and point-of-care (POC) testing holds tremendous potential in terms of determining pathogens quickly and multiplexed along with monitoring chronic conditions. An example of how nanomedicine is working in the real world occurred with the COVID-19 pandemic, which catalyzed the development of gold and magnetic nanoparticle-based diagnostics platforms into the field and mRNA-based vaccines. Notwithstanding these developments, there is still a set of troubles associated with scalability of manufacturing, standardization of regulations and ethical governance. The major ethical concerns are human enhancement, surveillance, and inequality in access to high-tech means on the global level. The article also discusses new technologies called DNA origami, nanobots and biohybrids-the ones which are expected to disrupt the precision medicine with the use of programmable and flexible systems. Being combined with genomics and systems biology, intelligent therapeutics that have dynamic molecular response are under way. Nevertheless, biocompatibility, autonomous regulation, and ostensibly fair use top modules are still subject to questioning. These grand challenges need multidisciplinary teamwork, a solid ethical ground, and convergence in regulatory approaches. The vision that was envisioned in this future is the ability of self-powered, AI-enabled Nano devices, providing real-time feedback, and able to transition the healthcare industry to a decentralized and personalized paradigm. The convergence of scientific novelty and social clarification empha

Scholars Academic Journal of PharmacyVol. 14(06)
Openalex Percentile: Top 2%
Biosensors and Analytical Detection
7.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.